Related Experiment Video
Updated: May 25, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Chagas heart disease: report on recent developments
Fabiana S Machado1, Linda A Jelicks, Louis V Kirchhoff
1Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Insights
Chagas disease, caused by the parasite Trypanosoma cruzi, leads to significant cardiac issues like cardiomyopathy and heart failure. Management focuses on symptoms, as antiparasitic treatment may not be suitable for advanced cases.
Area of Science:
- Cardiology
- Infectious Diseases
- Parasitology
Background:
- Chagas disease, caused by Trypanosoma cruzi, is a major cause of cardiac disease in Latin America.
- Increasing immigration leads to Chagas disease diagnoses in nonendemic regions.
- Cardiac manifestations include dilated cardiomyopathy, heart failure, arrhythmias, cardioembolism, and stroke.
Purpose of the Study:
- To define the pathology of Trypanosoma cruzi infection.
- To elucidate cellular and molecular mechanisms of Chagas heart disease.
- To inform clinical management strategies for Chagas heart disease.
Main Methods:
- Clinical research on Chagas disease patients.
- Laboratory-based investigations into T. cruzi infection pathology.
- Review of existing literature on Chagas heart disease management.
Main Results:
- Research has illuminated cellular and molecular pathways in T. cruzi-induced cardiac pathology.
- Antiparasitic treatment may be contraindicated in advanced Chagas heart disease.
- Cardiac transplantation is a viable option for select patients.
Conclusions:
- Chagas heart disease presents with diverse cardiac complications.
- Management parallels other cardiomyopathies; antiparasitic therapy is context-dependent.
- Cardiac transplantation offers a therapeutic avenue for end-stage Chagas heart disease.
Abstract:
Chagas disease, caused by the parasite Trypanosoma cruzi, is an important cause of cardiac disease in endemic areas of Latin America. It is now being diagnosed in nonendemic areas because of immigration. Typical cardiac manifestations of Chagas disease include dilated cardiomyopathy, congestive heart failure, arrhythmias, cardioembolism, and stroke. Clinical and laboratory-based research to define the pathology resulting from T. cruzi infection has shed light on many of the cellular and molecular mechanisms leading to these manifestations. Antiparasitic treatment may not be appropriate for patients with advanced cardiac disease. Clinical management of Chagas heart disease is similar to that used for cardiomyopathies caused by other processes. Cardiac transplantation has been successfully performed in a small number of patients with Chagas heart disease.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Heart Failure II: Pathophysiology
Rheumatic Heart Disease III: Medical Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Heart Failure III: Clinical Manifestations

